P. Shaw

Dual inhibition of epidermal growth factor and insulin-like 1 growth factor receptors reduce intestinal adenoma burden in the Apcmin/+ mouse

A. Clarke, T. Maughan, P. Shaw, 2011, British Journal of Cancer.

Assessment of the In Vivo Activity of PI3K and MEK Inhibitors in Genetically Defined Models of Colorectal Cancer

Geraint T. Williams, A. Clarke, M. Raja, 2015, Molecular Cancer Therapeutics.

Functional redundancy between Apc and Apc2 regulates tissue homeostasis and prevents tumorigenesis in murine mammary epithelium

H. Clevers, A. Grigoriadis, J. van Es, 2016, Oncogene.

Murine models of intestinal cancer: recent advances.

A. Clarke, P. Shaw, 2007, DNA repair.

Where now for anti-EGF receptor therapies in colorectal cancer?

R. Adams, P. Shaw, 2011, Expert review of anticancer therapy.

3D imaging of colorectal cancer organoids identifies responses to Tankyrase inhibitors

T. Dale, K. Ewan, A. Clarke, 2019, bioRxiv.

Pleurodesis for malignant pleural effusions.

R. Agarwal, P. Shaw, P. Shaw, 2013, The Cochrane database of systematic reviews.

Where now for anti-EGF receptor therapies in colorectal cancer?

R. Adams, P. Shaw, Paul Shaw, 2011, Expert review of anticancer therapy.